Clinical Trials in South Korea / NCT07446088
Active, not recruiting
Not applicable
Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
NCT07446088 · tracked via the Priya Life Science South Korea tracker
Condition(s) studied
Improving Blood CirculationBlood Circulation
Investigational drug(s) / intervention(s)
CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401)
CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401): Improving blood circulation device (Ceragem Celltron Circulation Chair)
Study summary
This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.
Eligibility
Inclusion Criteria:
* Adults aged between 19 and 65 years
* Individuals with a BMI of 30.0 kg/m² or less
* Individuals without abnormal findings on hematology tests (CBC)
Exclusion Criteria:
* Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest)
* Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.)
* Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions
* Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)
Primary outcome measure(s)
- Change and percent change in blood flow of the dorsal metacarpal vein — from baseline to immediately after a 30-minute application of the investigational device
Change and percent change in blood flow of the dorsal metacarpal vein from baseline to immediately after a 30-minute application of the investigational device
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Wonju Severance Christian Hospital | Wŏnju | South Korea |
More Ceragem Clinical Inc. trials in South Korea
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07446088 on ClinicalTrials.gov ↗ ← All trials in South Korea